前收市價 | 62.66 |
開市 | 62.72 |
買盤 | 64.04 x 100 |
賣出價 | 64.19 x 400 |
今日波幅 | 62.49 - 64.36 |
52 週波幅 | 51.79 - 89.91 |
成交量 | |
平均成交量 | 1,093,892 |
市值 | 10.07B |
Beta 值 (5 年,每月) | 1.22 |
市盈率 (最近 12 個月) | 46.09 |
每股盈利 (最近 12 個月) | 1.39 |
業績公佈日 | 2024年5月01日 |
遠期股息及收益率 | 0.32 (0.50%) |
除息日 | 2024年2月09日 |
1 年預測目標價 | 80.55 |
Last year was a tough one for biotech stocks. The Securities and Exchange Commission reported 41 bankruptcies following the Fed’s interest rate hiking cycle, making it difficult to finance debt. Yet, by the end of the year, the biotech sector started to recover. Over one year, BlackRock’s iShares Biotechnology ETF (NASDAQ:IBB) is now up 10%, but down -1.3% year-to-date. Due to negative market sentiment, some biotech stocks are more discounted than others. But which biotech stocks have sounder fu
Why do you want to consider biotech stocks? Simply, the narrative comes down to numbers and a possible rotation. First, the hard data supports bullishness in biotech stocks. According to Grand View Research, the underlying global industry reached a valuation of $1.55 trillion last year. Moving forward, experts project that the sector will expand at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030. At the culmination point, the space may be worth $3.88 trillion. Second, a sector r
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]